Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland - a prospective, observational POLONEZ II study considering patients reported outcomes.

被引：0
|
作者：
Liebert, A. [1 ]
Klopocka, M. [1 ]
Cichoz-Lach, H. [2 ]
Michalak, A. [2 ]
Talar-Wojnarowska, R. [3 ]
Domzal-Magrowska, D. [3 ]
Filipiuk, A. [4 ]
Krogulecki, M. [4 ]
Kopertowska-Majchrzak, M. [5 ]
Eder, P. [6 ]
Stawczyk-Eder, K. [6 ]
Waszak, K. [6 ]
Zagorowicz, E. [7 ,8 ]
Wojciechowski, K. [9 ,10 ]
Drygala, S. [9 ]
机构：
[1] Nicolaus Copernicus Univ, Coll Medicum Bydgoszcz, Dept Gastroenterol & Nutr Disorders, Bydgoszcz, Poland
[2] Med Univ Lublin, Dept Gastroenterol, Lublin, Poland
[3] Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland
[4] Mil Inst Med, Dept Gastroenterol, Warsaw, Poland
[5] Gen Hosp, Dept Internal Dis, Miedzychod, Poland
[6] Poznan Univ Med Sci, H Swiecicki Univ Hosp, Dept Gastroenterol Dietet & Internal Dis, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol, Warsaw, Poland
[8] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland
[9] Takeda Pharma Sp Zoo, Med Affairs, Warsaw, Poland
[10] Dept Internal Dis, Independent Publ Hlth Care Ctr, Tarczyn, Poland
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P421
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [21] Characteristics of Patients With Crohn's Disease Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufil
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S773 - S774
  • [22] Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center
    Hoffmann, Peter
    Krisam, Johannes
    Stremmel, Wolfgang
    Gauss, Annika
    DIGESTIVE DISEASES, 2019, 37 (01) : 33 - 44
  • [23] REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY
    Eriksson, Carl
    Rundquist, Sara
    Lykiardopoulos, Byron
    Udumyan, Ruzan
    Karlen, Per
    Grip, Olof
    Soderman, Charlotte
    Almer, Sven
    Hertervig, Erik
    Gunnarsson, Jenny
    Malmgren, Carolina
    Delin, Jenny
    Strid, Hans
    Sjoberg, Mats
    Oberg, David
    Daniel, Bergemalm
    Hjortswang, Henrik
    Halfvarson, Jonas
    GASTROENTEROLOGY, 2020, 158 (06) : S963 - S963
  • [24] A real-world study of outcomes in biologic-naive patients with Crohn's disease and ulcerative colitis initiating vedolizumab
    Raluy, M.
    Alam, N.
    Donaldson, R.
    Smyth, M.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S238 - S238
  • [25] Effectiveness and safety of adalimumab in patients with intestinal Behçet's disease: a real-world prospective observational study in South Korea
    Yu, Jongwook
    Shin, Sung Jae
    Park, Yune-Jung
    Kim, Hyung Wook
    Lee, Bo-In
    Ye, Byong Duk
    Kim, Geun-Tae
    Kim, Sung Kook
    Kim, Joo Sung
    Kim, Young-Ho
    Jeong, Seonjeong
    Cheon, Jae Hee
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [26] Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea
    Jongwook Yu
    Sung Jae Shin
    Yune-Jung Park
    Hyung Wook Kim
    Bo-In Lee
    Byong Duk Ye
    Geun-Tae Kim
    Sung Kook Kim
    Joo Sung Kim
    Young-Ho Kim
    Seonjeong Jeong
    Jae Hee Cheon
    BMC Gastroenterology, 23
  • [27] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
    Bressler, B.
    Mantzaris, G.
    Silverberg, M.
    Zezos, P.
    Stein, D.
    Colby, C.
    Lissoos, T.
    Lopez, C.
    Natsios, A.
    Radulescu, G.
    Patel, H.
    Demuth, D.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S427 - S428
  • [28] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 116 - 117
  • [29] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 768 - 769
  • [30] REAL-WORLD CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN BIOLOGIC-NAIVE PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE EVOLVE EXPANSION STUDY
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Bassel, Marielle
    Kamble, Pravin
    Adsul, Shashi
    Gianchetti, Lauren
    Scharl, Michael M.
    GASTROENTEROLOGY, 2023, 164 (06) : S5 - S5
12345